During the past decade, Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente" conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Galapagos NV" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "BioCryst Pharmaceuticals" with 1 trials sponsored and "Children's Hospital of Eastern Ontario" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Pontificia Universidad Catolica de Chile" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" are "Lung Diseases, Interstitial" (3 trials), "Rheumatoid Arthritis" (2 trials), "Anastomotic Leak" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" in a lesser frequency.

Most popular intervention types in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" are "Drug" (14 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Nintedanib" (4 trials), "GLPG0634" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente"". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente", undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínico Reg. de Concepción "Dr. G. Grant Benavente", 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".